1. A clinicopathologic analysis of adriamycin cardiotoxicity;Lefrak;Cancer,1973
2. Adriamycin (NSC-123127) cardiotoxicity: a clinicopathologic correlation;Cortes;Cancer Chemother Rep,1975
3. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy;Brislow;Am Heart J,1981
4. Anthracycline cardiomyopathy monitored by morphologic changes;Billingham;Cancer Treat Rep,1978
5. Invasive and noninvasive methods for assessing Adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy;Mason;Cancer Treat Rep,1978